Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression
Authors:
- 1 November 2010
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 123 (11) , 1001-1006
Abstract
No abstract availableKeywords
Funding Information
- Canada Foundation for Innovation
- Canadian Institutes of Health Research
This publication has 24 references indexed in Scilit:
- Inhaled corticosteroids in COPD: a case in favourEuropean Respiratory Journal, 2009
- Inhaled corticosteroids in COPD: the case against: Fig. 1—European Respiratory Journal, 2009
- The Association of Inhaled Corticosteroid Use with Serum Glucose Concentration in a Large CohortThe American Journal of Medicine, 2009
- Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEuropean Respiratory Journal, 2008
- Use of combination therapy in asthma: Are they prescribed according to guidelinesRespiratory Medicine, 2007
- Low-dose inhaled and nasal corticosteroid use and the risk of cataractsEuropean Respiratory Journal, 2006
- Epidemiology and costs of chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2006
- The Global Burden of Chronic DiseasesJAMA, 2004
- Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderlyJournal of General Internal Medicine, 2002
- Inhaled corticosteroids and the risk of diabetes among the elderlyBritish Journal of Clinical Pharmacology, 2002